Biomedicine & Pharmacotherapy (Nov 2022)

The role of lncRNA just proximal to XIST (JPX) in human disease phenotypes and RNA methylation: The novel biomarker and therapeutic target potential

  • Yirui Kuang,
  • Wenyue Shen,
  • Hecheng Zhu,
  • Haoxuan Huang,
  • Quanwei Zhou,
  • Wen Yin,
  • Yi Zhou,
  • Yudong Cao,
  • Lei Wang,
  • Xuewen Li,
  • Caiping Ren,
  • Xingjun Jiang

Journal volume & issue
Vol. 155
p. 113753

Abstract

Read online

Increasing evidence suggests that long non-coding RNAs (lncRNAs) are closely related to the initialization and development of human diseases. lncRNA just proximal to XIST (JPX), as a newly identified lncRNA, has been reported to be aberrantly expressed and associated with pathophysiological traits in numerous diseases, particularly cancers. More importantly, JPX has been proven to play important roles in various biological functions, including cell proliferation, migration, invasion, apoptosis, chemoresistance, and differentiation. In addition, we discuss the diverse molecular mechanisms and correlation with RNA methylation of JPX in several cancers. In this Review, we summarize current studies on JPX's roles in diseases and its potential application as a biomarker for both diagnoses and prognoses and a therapeutic target in human diseases.

Keywords